Investing in Innovation to Treat Chronic Disease

Project Invested
Project Invested
Published in
1 min readAug 3, 2016

BioTechnology is a very important sector within the U.S. economy, employing over 100,000 people with revenues of Biotech firms exceeding $80 billion. Continued investment and innovation in this sector is necessary to reduce the economic and societal burden that chronic disease have.

Learn more about this important sector of our economy from Members of Congress and BioTechnology industry analysts below:

--

--

Project Invested
Project Invested

Brought to you by @SIFMA. Providing a forum to explore and discuss key concepts that underlie the market economy.